Clinical Trial Update: Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Vincristine sulfate liposome injection with UK ALL R3 induction chemotherapy for pediatric acute lymphoblastic leukemia has completed; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Marqibo (vincristine liposome)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: ALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Status: COMPLETED | Results posted: 2025-10-22